Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Marketed under the brand names Mounjaro for type 2 diabetes and Zepbound for chronic weight management, tirzepatide was approved by the FDA in May 2022 and November 2023, respectively
Trumps deal promises lower government pricing and copays, which is considered a game-changer for the 65 million people currently on Medicare
I could barely drink my bedtime alcohol anymore
Related Factsheets This service is free for every family who needs it
US$ 24.20
US$ 24.93
US$ 20.40
US$ 23.91
US$ 21.62
US$ 27.05
US$ 21.41
US$ 23.69
